Latest Conference Articles

When is it not glaucoma: Masquerade syndromes

When is it not glaucoma: Masquerade syndromes

January 30th 2021

GLAUCOMA 360

Joseph F. Panarelli, MD, associate professor of ophthalmology, NYU Langone Medical Center, shares some clinical pearls for managing masquerade syndromes and determining when it is not glaucoma.

Studying glaucoma epidemiology at the center of the Earth

Studying glaucoma epidemiology at the center of the Earth

January 30th 2021

GLAUCOMA 360

Donald L. Budenz, MD, MPH, shares the key takeaways from his Shaffer-Hetherington-Hoskins Lecture, focusing on glaucoma epidemiology, presented during the 2021 Glaucoma 360's 25th Annual Glaucoma Symposium CME.

Visus CEO updates on lead product candidate, 2021 pipeline

Visus CEO updates on lead product candidate, 2021 pipeline

January 27th 2021

AAO

Visus Therapeutics CEO Ben Bergo shares an update on the status of its lead product candidate for presbyopia treatment as well as what's in the company's pipeline for 2021.

Clear lens extraction surgery: Pinpointing the optimal time in glaucoma patients

Clear lens extraction surgery: Pinpointing the optimal time in glaucoma patients

January 24th 2021

GLAUCOMA 360

The traditional treatment for primary angle-closure (PAC) and PAC glaucoma (PACG) is laser peripheral iridotomy (LPI) to facilitate aqueous outflow followed by medical treatment with drops to decrease the intraocular pressure (IOP).

Glaucoma and dry eye present double trouble for patients, ophthalmologists

Glaucoma and dry eye present double trouble for patients, ophthalmologists

January 24th 2021

GLAUCOMA 360

Sunita Radhakrishnan, MD, in a presentation at the 25th annual Glaucoma Symposium at the Glaucoma 360 virtual annual event, noted that concomitant treatment of both glaucoma and dry eye is key.

Analyzing effects of corneal biomechanics on IOP

Analyzing effects of corneal biomechanics on IOP

January 24th 2021

GLAUCOMA 360

Robert L. Stamper, MD, discusses the findings of a study analyzing the effects of corneal mechanics on IOP, presented during the virtual Glaucoma 360 meeting.

Treating PAC, PAC glaucoma with CLE

Treating PAC, PAC glaucoma with CLE

January 23rd 2021

GLAUCOMA 360

During the 2021 Glaucoma 360 meeting, Ruth D. Williams, MD, speaks on the highlights and key findings from the EAGLE study, which showed clear lens extraction surgery may be a better initial treatment for some glaucoma patients.

What this year’s global virtual Glaucoma 360 will look like

What this year’s global virtual Glaucoma 360 will look like

January 23rd 2021

GLAUCOMA 360

Andrew Iwach, MD, and Adrienne Graves, PhD, co-founders of Glaucoma 360, preview what attendees will experience at the 2021 version of the CME/CE Symposia, Annual Gala, and New Horizons Forum.

Glaucoma Research Foundation announces award recipients at G360 virtual annual gala

Glaucoma Research Foundation announces award recipients at G360 virtual annual gala

January 21st 2021

GLAUCOMA 360

Amid a pandemic, the Glaucoma Research Foundation is holding its annual gala online, funding aspirations for a glaucoma-free world with a goal of raising $1 million.

Comparing micro-bypass implant + phaco vs phaco in POAG

Comparing micro-bypass implant + phaco vs phaco in POAG

December 23rd 2020

AAO

Thomas Samuelson, MD, speaks on the outcomes of a three-year trial analyzing the iStent inject trabecular micro-bypass + phaco versus phaco alone in patients with POAG.